Matthew Harrison
Stock Analyst at Morgan Stanley
(3.42)
# 957
Out of 4,966 analysts
698
Total ratings
49.18%
Success rate
3.47%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $15.27 | +96.46% | 13 | Aug 18, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $34.73 | +138.99% | 13 | Aug 12, 2025 | |
| IOBT IO Biotech | Maintains: Overweight | $6 → $4 | $1.58 | +153.16% | 6 | Aug 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $391.02 | +12.27% | 41 | Aug 5, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $754 → $761 | $580.70 | +31.05% | 55 | Aug 4, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $146 → $144 | $132.22 | +8.91% | 54 | Aug 1, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $700 → $766 | $712.24 | +7.55% | 25 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $18.20 | +9.89% | 38 | Jul 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $97 → $96 | $58.27 | +64.75% | 22 | Jul 22, 2025 | |
| INSM Insmed | Maintains: Overweight | $102 → $108 | $136.10 | -20.65% | 18 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $187.52 | +14.65% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $112.97 | +19.50% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.36 | +78.57% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $32 | $24.09 | +32.84% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.13 | +342.48% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $166.49 | +6.91% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $37.40 | +49.73% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $33.97 | +61.91% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.35 | +27.66% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $16.79 | -34.48% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.69 | +373.37% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.57 | +172.37% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $21.65 | +57.04% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $24.87 | +28.67% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.24 | +486.42% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.97 | +2.77% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.43 | -51.05% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $6.48 | +23.46% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $31.44 | +39.95% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.06 | +324.84% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $11.08 | +622.02% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.13 | +1,069.59% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $100.00 | +116.00% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.07 | +62.87% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.13 | +134.74% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $210.40 | -13.50% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $9.04 | -0.44% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $46.73 | -14.40% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $287.71 | -1.98% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $446.51 | -52.97% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.76 | +110.02% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $177.17 | -2.35% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $29.96 | +300.53% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $15.39 | +861.66% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $84.12 | -2.52% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $47.18 | +39.89% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.92 | +1,235.62% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $35.98 | +27.85% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.42 | +271.55% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $732.58 | -62.46% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.79 | +581.00% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.93 | +594.29% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.81 | -3.14% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $84.61 | -1.90% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $35.33 | -71.70% | 4 | Sep 10, 2018 |
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $15.27
Upside: +96.46%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $34.73
Upside: +138.99%
IO Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $1.58
Upside: +153.16%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $391.02
Upside: +12.27%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Overweight
Price Target: $754 → $761
Current: $580.70
Upside: +31.05%
Biogen
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $146 → $144
Current: $132.22
Upside: +8.91%
argenx SE
Aug 1, 2025
Maintains: Overweight
Price Target: $700 → $766
Current: $712.24
Upside: +7.55%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $18.20
Upside: +9.89%
BioMarin Pharmaceutical
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $58.27
Upside: +64.75%
Insmed
Jul 17, 2025
Maintains: Overweight
Price Target: $102 → $108
Current: $136.10
Upside: -20.65%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $187.52
Upside: +14.65%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $112.97
Upside: +19.50%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.36
Upside: +78.57%
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $24.09
Upside: +32.84%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.13
Upside: +342.48%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $166.49
Upside: +6.91%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $37.40
Upside: +49.73%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $33.97
Upside: +61.91%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.35
Upside: +27.66%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $16.79
Upside: -34.48%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.69
Upside: +373.37%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.57
Upside: +172.37%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $21.65
Upside: +57.04%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $24.87
Upside: +28.67%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.24
Upside: +486.42%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.97
Upside: +2.77%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.43
Upside: -51.05%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $6.48
Upside: +23.46%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $31.44
Upside: +39.95%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.06
Upside: +324.84%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $11.08
Upside: +622.02%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.13
Upside: +1,069.59%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $100.00
Upside: +116.00%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.07
Upside: +62.87%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.13
Upside: +134.74%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $210.40
Upside: -13.50%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $9.04
Upside: -0.44%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $46.73
Upside: -14.40%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $287.71
Upside: -1.98%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $446.51
Upside: -52.97%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.76
Upside: +110.02%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $177.17
Upside: -2.35%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $29.96
Upside: +300.53%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $15.39
Upside: +861.66%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $84.12
Upside: -2.52%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $47.18
Upside: +39.89%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.92
Upside: +1,235.62%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $35.98
Upside: +27.85%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.42
Upside: +271.55%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $732.58
Upside: -62.46%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.79
Upside: +581.00%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.93
Upside: +594.29%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.81
Upside: -3.14%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $84.61
Upside: -1.90%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $35.33
Upside: -71.70%